Impaired B Cell and cTfh Immune Pathways Underlie Influenza Vaccine Hyporesponsiveness in Older, Frail, and Multimorbid Adults 2309992

Abstract Introduction Older adults face the highest rates of influenza-related hospitalization and death due to immunosenescence and diminished vaccine responsiveness. Despite the use of high-dose and adjuvanted flu vaccines, substantial variability persists. The biological features distinguishing robust (“Hyper”) from poor (“Hypo”) vaccine responders (HyperR and HypoR) remain unclear. By integrating B cell and circulating T follicular helper cell (cTfh) activation, and RNA-seq transcriptional analysis, we identified coordinated signatures underlying response heterogeneity between HyperR and HypoR cohorts. Methods Samples from 21 frail multimorbid nursing home residents receiving flu vaccine were analyzed across visits (D0, D28). Hemagglutinin inhibition assays (HAI) quantified ab response to define HypoR and HyperR cohorts. Differential expression and pathway analyses of RNAseq data were performed after mitogenic stimulation of purified cTfh and B-cells. Results Transcriptomic profiling showed enrichment of antigen presentation, germinal-center differentiation, and metabolic activation pathways in HyperR. A Custom Nakaya B-cell pathway showed markedly higher expression in HyperR and reduced expression in HypoR, with AICDA (somatic hypermutation enzyme) as the most highly differentially expressed gene. Additional B-cell genes associated with survival and differentiation (BCL2L10, TBX21, CD27) were increased in HyperR. cTfh cells from HyperR showed increased expression of helper and trafficking genes (IL21, CXCR5, CXCL13, CRTAM). In contrast, HypoR exhibited attenuated pathway activity, increased TIGIT (checkpoint receptor) expression, and weakened concordance between cellular and antibody responses. Conclusion HyperR to flu vaccination mount coordinated cellular and molecular responses, whereas HypoR show reduced activation and fragmented B-cell proliferation and plasmablast maturation signaling. Our findings highlight putative mechanisms to inform improvements in influenza protection in frail adults. Funding Source 1R01AI129709-01A1 Topic Categories Vaccines and Immunotherapy (VAC)

Authors

Institutions

Publication Details

Journal
The Journal of Immunology
Published
2026-07-28
DOI
https://doi.org/10.1093/jimmun/vkag141.1663
Primary Topic
Influenza Virus Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Impaired B Cell and cTfh Immune Pathways Underlie Influenza Vaccine Hyporesponsiveness in Older, Frail, and Multimorbid Adults 2309992

Banumathi Tamilselvan, Brian Richardson, Mark Cameron, David Canaday et al.
The Journal of Immunology
Influenza Virus Research Studies
article

Impaired B Cell and cTfh Immune Pathways Underlie Influenza Vaccine Hyporesponsiveness in Older, Frail, and Multimorbid Adults 2309992

Banumathi Tamilselvan, Brian Richardson, Mark Cameron, David Canaday, Cheryl Cameron, Joseph Kass
article en

Abstract

Abstract Introduction Older adults face the highest rates of influenza-related hospitalization and death due to immunosenescence and diminished vaccine responsiveness. Despite the use of high-dose and adjuvanted flu vaccines, substantial variability persists. The biological features distinguishing robust (“Hyper”) from poor (“Hypo”) vaccine responders (HyperR and HypoR) remain unclear. By integrating B cell and circulating T follicular helper cell (cTfh) activation, and RNA-seq transcriptional analysis, we identified coordinated signatures underlying response heterogeneity between HyperR and HypoR cohorts. Methods Samples from 21 frail multimorbid nursing home residents receiving flu vaccine were analyzed across visits (D0, D28). Hemagglutinin inhibition assays (HAI) quantified ab response to define HypoR and HyperR cohorts. Differential expression and pathway analyses of RNAseq data were performed after mitogenic stimulation of purified cTfh and B-cells. Results Transcriptomic profiling showed enrichment of antigen presentation, germinal-center differentiation, and metabolic activation pathways in HyperR. A Custom Nakaya B-cell pathway showed markedly higher expression in HyperR and reduced expression in HypoR, with AICDA (somatic hypermutation enzyme) as the most highly differentially expressed gene. Additional B-cell genes associated with survival and differentiation (BCL2L10, TBX21, CD27) were increased in HyperR. cTfh cells from HyperR showed increased expression of helper and trafficking genes (IL21, CXCR5, CXCL13, CRTAM). In contrast, HypoR exhibited attenuated pathway activity, increased TIGIT (checkpoint receptor) expression, and weakened concordance between cellular and antibody responses. Conclusion HyperR to flu vaccination mount coordinated cellular and molecular responses, whereas HypoR show reduced activation and fragmented B-cell proliferation and plasmablast maturation signaling. Our findings highlight putative mechanisms to inform improvements in influenza protection in frail adults. Funding Source 1R01AI129709-01A1 Topic Categories Vaccines and Immunotherapy (VAC)

The Journal of ImmunologyVol. 215(Supplement_1)
Louis Stokes Cleveland VA Medical Center (US), Case Western Reserve University (US)
No poverty
Openalex Percentile: Top 8%
Influenza Virus Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.